Skip to main content
Top
  • Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Two Lots of NP Thyroid®, Thyroid Tablets, USP Due to Sub Potency

    Friday, September 18, 2020
    Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level. The products are being recalled because testing has found these lots to be sub potent. The product may...

    Read More
  • Becton Dickinson (BD) CareFusion 303 Inc. Recalls Alaris™ Syringe and Alaris™ PCA Modules Due to Potential Incorrect Display of Syringe Types and/or Sizes

    Thursday, September 17, 2020
    BD/Carefusion 303 is recalling the Alaris™ Syringe Module and Alaris™ PCA Module because the Alaris PC units may display the incorrect syringe types and/or sizes. This could potentially result in delays in infusion, under-infusion, or over-infusion. If this occurs, this could lead to...

    Read More
  • Becton Dickinson (BD) CareFusion 303 Recalls Alaris System Infusion Pumps Due to Damaged Inter-Unit Interface Connectors, Loose or Missing Battery Screws and A Broken Upper and Lower Hinge Posts and Membrane Frame

    Tuesday, September 15, 2020
    BD/CareFusion 303 is recalling the Alaris Infusion Pump System due to the following hardware situations: Situation 1: Damaged Inter-Unit Interface (IUI) Connectors (Class 1 Recall) Situation 2: Broken elements on Alaris™ Pump Module platen (Class 1 Recall) Situation 3: Improperly secured PC...

    Read More
  • Becton Dickinson (BD) CareFusion 303, Inc. Recalls Alaris™ System PC Unit and PC Unit Front Case Keypad Replacement Kits Due to Risk of Stuck or Unresponsive Keys

    Tuesday, September 15, 2020
    BD/CareFusion 303 is recalling the Alaris™ PC unit and PC Unit Front Case with Keypad Replacement Kits because the keypad may have one or more keys in the keypad that become unresponsive or stuck. This could lead to an infusion delay or prevent clinicians from changing fluid or medication...

    Read More
  • BD Provides Update on Previously Disclosed Recall of BD Alaris System Hardware

    Thursday, September 3, 2020
    Three of the situations described in this recall, which BD announced on June 30, 2020, have been designated as Class I recalls by the U.S. Food and Drug Administration (FDA), which means that there is a reasonable probability that the use of the product will cause serious adverse health...

    Read More
  • Mylan Initiates Voluntary Nationwide Recall of Four Lots of Amiodarone HCl Injection, USP and Tranexamic Acid Injection, USP Due to Carton Label Mix-Up

    Tuesday, September 1, 2020
    Mylan N.V.External Link Disclaimer (NASDAQ: MYL) today announced that its U.S.-based Mylan Institutional LLC business is conducting a voluntary nationwide recall to the hospital/clinic level of four lots of Amiodarone HCl Injection, USP 450 mg/9 mL, packaged in cartons of 10 single-dose 9 mL vials...

    Read More
  • Hurricane Laura—Clinical Guidance for Carbon Monoxide (CO) Poisoning

    Friday, August 28, 2020
    The Centers for Disease Control and Prevention (CDC) is reminding clinicians seeing patients from the areas affected by Hurricane Laura to maintain a high index of suspicion for CO poisoning. Other people who may be exposed to the same CO source may need to be identified and assessed.

    Read More
  • Invokana, Invokamet, Invokamet XR: MedWatch Safety Alert - Boxed Warning about Risk of Leg and Foot Amputations Removed

    Wednesday, August 26, 2020
    Based on FDA's review of new data from three clinical trials, the boxed warning about amputation risk from the diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR) was removed from the prescribing information.

    Read More
  • Smiths Medical Recalls Medfusion 3500 and 4000 Syringe Pumps Due to Risk of Medication Delivery Error

    Tuesday, August 25, 2020
    Smiths Medical is recalling specific software versions of the Medfusion 3500 and 4000 Syringe Pumps because of a software error that may lead to over-delivery or under-delivery of fluids or medication. Over- or under-delivery can occur if the following specific sequence of events occur: a bolus or...

    Read More
  • Bayshore Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets

    Friday, August 21, 2020
    Bayshore Pharmaceuticals, LLC, Short Hills, NJ is voluntarily recalling one (1) lot of Metformin Hydrochloride Extended-Release Tablets USP, 500 mg, 1000 count bottles and one (1) lot of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, 100 count bottles within expiry to the consumer...

    Read More